Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | TK2 | O00142 | 4/20 | 0.48 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25402244 | 1.00 | LMNA (0.50) | LMNATHRBSMN1; SMN2HIF1ATK2 | |
| SCHEMBL9069552 | 0.95 | TK2 (0.53) | LMNATHRBSMN1; SMN2HIF1ATK2 | |
| SCHEMBL9069522 | 0.91 | CA12 (0.49) | LMNATHRBSMN1; SMN2HIF1ATK2 | |
| SCHEMBL5566835 | 0.87 | CA12 (0.47) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL15279673 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL12900042 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL16455208 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL12928917 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL10350038 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 | |
| Uridine Triacetate SCHEMBL14950624 | 0.87 | LMNA (0.64) | LMNATHRBSMN1; SMN2HIF1AP2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357304-A1 | 2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position | WELLSTAT THERAPEUTICS CORPORATION | 2023-11-09 | — | — | US | disclosed |
| US-20230357304-A1 | 2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position | WELLSTAT THERAPEUTICS CORPORATION | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357304-A1 | 2′,3′-Diacetyluridine Substituted With Acetoacetyl at the 5′ Position | ACAT1, ACADVL, ACAA2 | LMNA 3476/4885THRB 3021/4885SMN1; SMN2 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.